Polygenic risk scores, which estimate a person's disease risk based on thousands or millions of common genetic variants, perform poorly in screening and prediction of common diseases such as heart disease, according to a ...
Oct 17, 2023
0
60
Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs. But targeted therapies can often inhibit other ...
Oct 16, 2023
0
27
A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor ...
Oct 12, 2023
0
38
The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.
Oct 6, 2023
0
7
UVA Health researchers have developed a powerful new tool to understand how medications affect men and women differently, and that will help lead to safer, more effective drugs in the future.
Oct 2, 2023
0
31
A team from the UCL Global Business School for Health (GBSH) and the UCL School of Pharmacy are using data collected from an "electric tongue" to create an AI model for predicting the bitterness of drugs.
Sep 22, 2023
0
5
University of Queensland researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumor regrowth in cancer patients.
Sep 21, 2023
0
1
An international team of scientists has created the first comprehensive index of human cells, mapping the sizes and abundance of all cell types across the entire body. This study, published in PNAS, reveals surprising mathematical ...
Sep 20, 2023
0
2
Developing new drugs is paramount in discovering innovative treatments and preventing diseases. This is vital not only for advancing medicine but also for the overall health and well-being of humanity. Yet, even when drugs ...
Sep 8, 2023
0
11
Professor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable ...
Aug 24, 2023
0
21
